National Bank of Canada
PLSE icon

National Bank of Canada’s Pulse Biosciences PLSE Stock Holding History

National Bank of Canada’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$6.65K – 2862
2023
Q2 		$6.65K Buy
+10
New +$64 ﹤0.01% 2279

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

National Bank of Canada's PLSE Position: Q1 2026 in Review

National Bank of Canada reduced its Pulse Biosciences (PLSE) stake by 1.4% in Q1 2026, selling an estimated $129 and leaving 493 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

National Bank of Canada first reported a position in PLSE in Q4 2022 and has held it in 14 quarters since. The position peaked at $26.3K in Q3 2024. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • National Bank of Canada held 493 shares of Pulse Biosciences worth $10.6K as of Q1 2026.
  • National Bank of Canada sold 7 Pulse Biosciences shares in Q1 2026, an estimated $129.
  • Pulse Biosciences made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2316 holding.
  • National Bank of Canada first reported a position in Pulse Biosciences in Q4 2022 and has held it in 14 quarters since.
  • National Bank of Canada's Pulse Biosciences position peaked at $26.3K in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.